Intelligent Bio Solutions Inc.
INBS
$1.41
$0.129.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.52% | -20.49% | 9.57% | 64.25% | 80.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.52% | -20.49% | 9.57% | 64.25% | 80.22% |
| Cost of Revenue | -39.95% | -31.94% | -6.79% | -122.28% | 52.19% |
| Gross Profit | 91.26% | 12.00% | 49.29% | 1,544.35% | 440.91% |
| SG&A Expenses | -0.75% | 6.11% | -20.68% | 9.80% | 27.75% |
| Depreciation & Amortization | -5.30% | 5.13% | -2.34% | 67.75% | -20.08% |
| Other Operating Expenses | -106.80% | 12.79% | -14.74% | -99.74% | 28.80% |
| Total Operating Expenses | -13.11% | 4.23% | 8.28% | 14.79% | 30.08% |
| Operating Income | 13.56% | -13.71% | -7.87% | -6.49% | -20.71% |
| Income Before Tax | 14.60% | -14.19% | -10.79% | -4.64% | 52.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.60% | -14.19% | -10.79% | -4.64% | 52.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -21.98% | 8.96% | 27.78% | -11.20% | 12.35% |
| Net Income | 14.58% | -14.21% | -10.74% | -4.71% | 53.06% |
| EBIT | 13.56% | -13.71% | -7.87% | -6.49% | -20.71% |
| EBITDA | 13.80% | -14.63% | -8.99% | -2.20% | -28.29% |
| EPS Basic | 69.22% | 76.09% | 94.36% | 96.38% | 97.91% |
| Normalized Basic EPS | 69.21% | 76.08% | 94.36% | 96.30% | 94.11% |
| EPS Diluted | 69.22% | 76.09% | 94.36% | 96.38% | 97.91% |
| Normalized Diluted EPS | 69.21% | 76.08% | 94.36% | 96.30% | 94.11% |
| Average Basic Shares Outstanding | 177.51% | 377.60% | 1,862.46% | 2,795.90% | 2,150.97% |
| Average Diluted Shares Outstanding | 177.51% | 377.60% | 1,862.46% | 2,795.90% | 2,150.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |